Pharmaceutical Product
- All
- News
- Videos
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Trump Announces New Tariffs: 100% On Drugs, 50% On Kitchen Cabinets, Others
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks starting on Oct. 1.
-
Trump Says Tariffs On Pharma, Chips Coming By "Next Week Or So"
US President Donald Trump signaled Tuesday that fresh tariffs on imported pharmaceuticals and semiconductors could be unveiled as soon as the coming week, as he presses on in efforts to reshape global trade.
-
AstraZeneca Moves Some Production To US Amid Tariff Threat
British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.
-
Pharma, Semi-conductors, Energy Products Exempted From Trump's Tariff
Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 26 per cent import duty announced by the US on Wednesday, according to think tank GTRI.
-
"Crucial Milestone": US Approves New Antibiotic For Urinary Tract Infections
The product -- called Blujepa -- was approved for the treatment of uncomplicated urinary tract infections in adult women and girls 12 and older.
-
Donald Trump Plans To Impose New Tariffs "Over Next Month". What's On Target
US President Donald Trump is planning to announce tariffs on more products as he pushes to shrink America's trade deficits, boost domestic manufacturing and achieve other policy goals.
-
Imitation Ozempic Floods Market: Understanding Risks, Costs, and Alternatives
The surge of imitation Ozempic products raises significant health and safety issues for consumers. With brand-name options priced between $800 and $1,000, many are turning to alternatives from compounding pharmacies and unregulated peptide sellers. These alternatives may not be safe or effective, lacking rigorous testing and quality control. As pha...
-
Johnson & Johnson To Pay $700 Million In Talc Safety Settlement
US pharmaceutical and cosmetics giant Johnson & Johnson has agreed to pay $700 million to settle allegations it misled customers about the safety of its talcum-based powder products, New York's attorney general announced Tuesday.
-
Pharma Firm Asked To Stop Production After 11 Workers Die In Maharashtra Plant Fire
Pharmaceutical firm Blue Jet Healthcare has been ordered to stop production and remove inflammable chemical goods from its premises after a fire in its factory in Raigad district killed 11 labourers this month.
-
Johnson & Johnson's $9 Billion Offer To Settle 'Talc Caused Cancer' Claims
US pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum powder products caused cancer.
-
Uzbekistan Child Deaths: Noida Syrup Manufacturer's Licence Suspended
The production licence of Noida-based pharmaceutical firm Marion Biotech, allegedly linked with the deaths of children in Uzbekistan, has been suspended while the test results of its controversial cough syrup are awaited, an UP drug official said.
-
WHO Drew Premature Link Between Gambia Child Deaths, Indian Cough Syrups: Drug Regulator
The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Trump Announces New Tariffs: 100% On Drugs, 50% On Kitchen Cabinets, Others
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks starting on Oct. 1.
-
Trump Says Tariffs On Pharma, Chips Coming By "Next Week Or So"
US President Donald Trump signaled Tuesday that fresh tariffs on imported pharmaceuticals and semiconductors could be unveiled as soon as the coming week, as he presses on in efforts to reshape global trade.
-
AstraZeneca Moves Some Production To US Amid Tariff Threat
British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.
-
Pharma, Semi-conductors, Energy Products Exempted From Trump's Tariff
Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 26 per cent import duty announced by the US on Wednesday, according to think tank GTRI.
-
"Crucial Milestone": US Approves New Antibiotic For Urinary Tract Infections
The product -- called Blujepa -- was approved for the treatment of uncomplicated urinary tract infections in adult women and girls 12 and older.
-
Donald Trump Plans To Impose New Tariffs "Over Next Month". What's On Target
US President Donald Trump is planning to announce tariffs on more products as he pushes to shrink America's trade deficits, boost domestic manufacturing and achieve other policy goals.
-
Imitation Ozempic Floods Market: Understanding Risks, Costs, and Alternatives
The surge of imitation Ozempic products raises significant health and safety issues for consumers. With brand-name options priced between $800 and $1,000, many are turning to alternatives from compounding pharmacies and unregulated peptide sellers. These alternatives may not be safe or effective, lacking rigorous testing and quality control. As pha...
-
Johnson & Johnson To Pay $700 Million In Talc Safety Settlement
US pharmaceutical and cosmetics giant Johnson & Johnson has agreed to pay $700 million to settle allegations it misled customers about the safety of its talcum-based powder products, New York's attorney general announced Tuesday.
-
Pharma Firm Asked To Stop Production After 11 Workers Die In Maharashtra Plant Fire
Pharmaceutical firm Blue Jet Healthcare has been ordered to stop production and remove inflammable chemical goods from its premises after a fire in its factory in Raigad district killed 11 labourers this month.
-
Johnson & Johnson's $9 Billion Offer To Settle 'Talc Caused Cancer' Claims
US pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum powder products caused cancer.
-
Uzbekistan Child Deaths: Noida Syrup Manufacturer's Licence Suspended
The production licence of Noida-based pharmaceutical firm Marion Biotech, allegedly linked with the deaths of children in Uzbekistan, has been suspended while the test results of its controversial cough syrup are awaited, an UP drug official said.
-
WHO Drew Premature Link Between Gambia Child Deaths, Indian Cough Syrups: Drug Regulator
The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.
